Welcome back to the Weekly! The Endpoints News team gathered a group of industry experts in Cambridge, MA this week to debate the future of China biotech. During one of ...
Welcome back to the Weekly! The Endpoints News team gathered a group of industry experts in Cambridge, MA this week to debate the future of …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Endpoints launches The China Biotech Debate, a panel series in Cambridge, MA, on Aug. 6, with execs from Roivant, Pfizer, Ginkgo…
Welcome back to Endpoints Weekly! Don’t miss Ryan Cross’ deep dive into the paranoia caused by competition with China. Ryan…
Welcome back to another edition of Endpoints Weekly. My usual colleague Nicole DeFeudis is out this week, so I’ve assembled the…
A handpicked article read aloud from the latest issue of The Economist
Welcome back to Endpoints Weekly! We had a small team in Chicago last weekend at this year’s ASCO conference. You’ll find a recap…
Welcome back to Endpoints Weekly! We’re gearing up for a busy week of earnings coverage, as Moderna, AstraZeneca, GSK, Bristol…
